Your browser doesn't support javascript.
loading
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Lakeman, Inge M M; van den Broek, Alexandra J; Vos, Juliën A M; Barnes, Daniel R; Adlard, Julian; Andrulis, Irene L; Arason, Adalgeir; Arnold, Norbert; Arun, Banu K; Balmaña, Judith; Barrowdale, Daniel; Benitez, Javier; Borg, Ake; Caldés, Trinidad; Caligo, Maria A; Chung, Wendy K; Claes, Kathleen B M; Collée, J Margriet; Couch, Fergus J; Daly, Mary B; Dennis, Joe; Dhawan, Mallika; Domchek, Susan M; Eeles, Ros; Engel, Christoph; Evans, D Gareth; Feliubadaló, Lidia; Foretova, Lenka; Friedman, Eitan; Frost, Debra; Ganz, Patricia A; Garber, Judy; Gayther, Simon A; Gerdes, Anne-Marie; Godwin, Andrew K; Goldgar, David E; Hahnen, Eric; Hake, Christopher R; Hamann, Ute; Hogervorst, Frans B L; Hooning, Maartje J; Hopper, John L; Hulick, Peter J; Imyanitov, Evgeny N; Isaacs, Claudine; Izatt, Louise; Jakubowska, Anna; James, Paul A; Janavicius, Ramunas; Jensen, Uffe Birk.
Afiliación
  • Lakeman IMM; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • van den Broek AJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Vos JAM; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Barnes DR; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Adlard J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK.
  • Arason A; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Arnold N; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Arun BK; Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland.
  • Balmaña J; BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Barrowdale D; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Benitez J; Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
  • Borg A; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Caldés T; Hereditary cancer Genetics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Caligo MA; Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, University Hospital of Vall d'Hebron, Barcelona, Spain.
  • Chung WK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Claes KBM; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Collée JM; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
  • Couch FJ; SOD Genetica Molecolare. University Hospital, Pisa, Italy.
  • Daly MB; Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA.
  • Dennis J; Centre for Medical Genetics, Ghent University, Ghent, Belgium.
  • Eeles R; Department of Clinical Genetics, Erasmus University Medical Center, CA, Rotterdam, The Netherlands.
  • Engel C; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Evans DG; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Feliubadaló L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Foretova L; Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, CA, USA.
  • Friedman E; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Frost D; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
  • Ganz PA; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Garber J; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Gayther SA; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Gerdes AM; Hereditary Cancer Program, ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
  • Godwin AK; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Goldgar DE; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Hahnen E; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
  • Hake CR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Hamann U; Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles, CA, USA.
  • Hogervorst FBL; Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hooning MJ; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core. Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Hopper JL; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Hulick PJ; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • Imyanitov EN; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Isaacs C; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Izatt L; Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Jakubowska A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • James PA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Janavicius R; Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.
  • Jensen UB; The University of Chicago Pritzker School of Medicine, Chicago, IL, USA.
Genet Med ; 23(9): 1726-1737, 2021 09.
Article en En | MEDLINE | ID: mdl-34113011
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos